THE EVOLVING ROLE OF DISEASE-LEVEL PATIENT EXPERIENCE IN HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REGULATORY DECISION-MAKING

被引：0
|
作者：
Hudzik, A. [1 ]
Sandman, K. [2 ]
Pham, S. [3 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] AESARA, Acton, MA USA
[3] AESARA, Chapel Hill, NC USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR6
引用
收藏
页码：S541 / S542
页数：2
相关论文
共 50 条
  • [21] UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING: GUIDANCE OF THE HTAI-DIA WORKING GROUP
    Hogervorst, M.
    Heikkinen, I
    Vreman, R. A.
    Oortwijn, W.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S9 - S9
  • [22] NEEDS AND RISKS ASSESSMENT IN CREATION OF HTA-INFORMED HEALTH CARE DECISION-MAKING ECOSYSTEM IN UKRAINE
    Romanenko, I
    Serediuk, V
    Zakharian, A.
    Piniazhko, O.
    Dumenko, T.
    Kahveci, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S798 - S799
  • [23] USING DECISION MAKING CLINICAL SCENARIOS TO APPRAISE PREFERENCES AND VALUE JUDGMENTS IN HEALTH TECHNOLOGY ASSESSMENT (HTA)
    Santoro Neto, L.
    Ferraz, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A520 - A520
  • [24] The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making
    Przepiorka, Donna
    de Claro, R. Angelo
    Pazdur, Richard
    [J]. JAMA ONCOLOGY, 2021, 7 (05) : 784 - 784
  • [25] Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
    Hogervorst, Milou Amber
    Vreman, Rick
    Heikkinen, Inkatuuli
    Bagchi, Indranil
    Gutierrez-Ibarluzea, Inaki
    Ryll, Bettina
    Eichler, Hans-Georg
    Petelos, Elena
    Tunis, Sean
    Sapede, Claudine
    Goettsch, Wim
    Janssens, Rosanne
    Huys, Isabelle
    Barbier, Liese
    DeJean, Deirdre
    Strammiello, Valentina
    Lingri, Dimitra
    Goodall, Melinda
    Papadaki, Magdalini
    Toussi, Massoud
    Voulgaraki, Despina
    Mitan, Ania
    Oortwijn, Wija
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [26] Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature
    Bujar, Magdalena
    McAuslane, Neil
    Walker, Stuart R.
    Salek, Sam
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [27] Giving patients a voice in Health Technology Assessment decision-making in Greece: a patient advocacy group consensus analysis
    Athanasakis, Kostas
    Naoum, Vasiliki
    Karampli, Eleftheria
    Naoum, Panagiota
    Pavi, Elpida
    Kyriopoulos, John
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (04) : 583 - 586
  • [28] Health technology assessment for decision-making in Latin America: good practice principles
    Pichon-Riviere, Andres
    Soto, Natalie C.
    Ariel Augustovski, Federico
    Garcia Marti, Sebastian
    Sampietro-Colom, Laura
    [J]. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2017, 41
  • [29] National guidance and local decision-making: is health technology assessment a help or a hindrance?
    Hutton, John
    [J]. EJHP PRACTICE, 2010, 16 (02): : 20 - 22
  • [30] Evidence-based decision-making and health technology assessment in South Korea
    Park, Seong-Hi
    Lee, Sang-Moo
    [J]. VALUE IN HEALTH, 2008, 11 : S163 - S164
12345